View Older Stories View More Recent Stories
-
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
-
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
-
FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Peptide Portfolio
-
Avidity Biosciences Inc. (RNA) Prices 15.22M Share Offering at $16.50/sh
-
Avidity Biosciences Announces Oversubscribed $400 Million Private Placement
-
Form SC 13D/A Connect Biopharma Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Jnana Therapeutics to Participate in Upcoming Investor Conferences
-
Form SC 13G Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Cytek Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
-
Form SC 13D/A Icosavax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
-
Form SC 13G/A EyePoint Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Tourmaline Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NEKTAR THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Day One Biopharmaceutica Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Apogee Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Cogent Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ALPINE IMMUNE SCIENCES, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A CureVac N.V. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Gracell Biotechnologies Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Harpoon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A CHIMERIX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RxSight, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ImmunoGen, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A HilleVax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A MACROGENICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Adagio Medical to Go Public via Merger with ARYA Sciences Acquisition Corp IV (ARYD)

